Kenneth Turteltaub

Personal Home Page

http://www-cmls.llnl.gov/?url=about_cmels-scientific_staff-turteltaub_k

Articles in Scholarly Journals [Incomplete List]

  1. A sample preparation protocol for quantification of radiolabeled nucleoside incorporation into DNA by accelerator mass spectrometry
    Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, vol. 259, no. 1, pp. 763–766, 2007
  2. BiodosEPR-2006 Meeting: Acute dosimetry consensus committee recommendations on biodosimetry applications in events involving uses of radiation by terrorists and radiation accidents
    Radiation Measurements, vol. 42, no. 6-7, pp. 972–996, 2007
  3. From the Cover: Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry
    Proceedings of the National Academy of Sciences, vol. 104, no. 27, pp. 11203–11208, 2007
  4. Tamoxifen Forms DNA Adducts in Human Colon after Administration of a Single [14C]-Labeled Therapeutic Dose
    Cancer Research, vol. 67, no. 14, pp. 6995–7002, 2007
  5. Inflammation and Atrophy Precede Prostatic Neoplasia in a PhIP-Induced Rat Model
    Neoplasia, vol. 8, no. 9, pp. 708–715, 2006
  6. Molecular Medicine, vol. 12, no. 7-8, p. 1, 2006
  7. The Urinary Metabolite Profile of the Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Is Predictive of Colon DNA Adducts after a Low-Dose Exposure in Humans
    Cancer Research, vol. 66, no. 21, pp. 10541–10547, 2006
  8. A novel14C-postlabeling assay using accelerator mass spectrometry for the detection ofO6-methyldeoxy-guanosine adducts
    Rapid Communications in Mass Spectrometry, vol. 20, no. 5, pp. 883–891, 2006
  9. Journal of Proteome Research, vol. 5, no. 10, pp. 2611–2619, 2006
  10. Accelerator Mass Spectrometry for Biomedical Research
    Methods in Enzymology, vol. 402, pp. 423–443, 2005
  11. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations
    Cancer Chemotherapy and Pharmacology, vol. 57, no. 3, pp. 335–342, 2005
  12. Statistical challenges in the analysis of two-dimensional difference gel electrophoresis experiments using DeCyderTM
    Bioinformatics, vol. 21, no. 19, pp. 3733–3740, 2005
  13. Serum Protein Profile Alterations in Hemodialysis Patients
    American Journal of Nephrology, vol. 24, no. 2, pp. 268–274, 2004
  14. Whole-genome amplification of DNA from residual cells left by incidental contact
    Analytical Biochemistry, vol. 324, no. 2, pp. 312–314, 2004
  15. The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure
    Food and Chemical Toxicology, vol. 42, no. 4, pp. 559–569, 2004
  16. Characterization of a peptide adduct formed by N-acetoxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), a reactive intermediate of the food carcinogen PhIP
    Food and Chemical Toxicology, vol. 42, no. 8, pp. 1367–1372, 2004
  17. Chemical Research in Toxicology, vol. 17, no. 12, pp. 1614–1620, 2004
  18. Structural characterization of carcinogen-modified oligodeoxynucleotide adducts using matrix-assisted laser desorption/ionization mass spectrometry
    Journal of Mass Spectrometry, vol. 38, no. 1, pp. 68–79, 2003
  19. The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats
    Chemico-Biological Interactions, vol. 145, no. 3, pp. 251–265, 2003
  20. Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA
    Carcinogenesis, vol. 23, no. 11, pp. 1897–1902, 2002
  21. Attomole Detection of in Vivo Protein Targets of Benzene in Mice: Evidence For A Highly Reactive Metabolite
    Molecular & Cellular Proteomics, vol. 1, no. 11, pp. 885–895, 2002
  22. Solution structure of the 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine C8-deoxyguanosine adduct in duplex DNA
    Proceedings of the National Academy of Sciences, vol. 98, no. 15, pp. 8507–8512, 2001
  23. Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine oligodeoxyribonucleotide adducts
    Nucleic Acids Research, vol. 29, no. 9, pp. 1951–1959, 2001
  24. Attomole quantitation of protein separations with accelerator mass spectrometry
    ELECTROPHORESIS, vol. 22, no. 10, pp. 2037–2045, 2001
  25. Methods of DNA adduct determination and their application to testing compounds for genotoxicity
    Environmental and Molecular Mutagenesis, vol. 35, no. 3, pp. 222–233, 2000
  26. Quantitation of benzo[a]pyrene-DNA adducts by postlabeling with 14C-acetic anhydride and accelerator mass spectrometry
    Chemico-Biological Interactions, vol. 126, no. 3, pp. 171–183, 2000
  27. Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical Research
    Current Pharmaceutical Design, vol. 6, no. 10, pp. 991–1007, 2000
  28. The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans
    Carcinogenesis, vol. 20, no. 4, pp. 705–713, 1999
  29. Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose
    International Journal of Cancer, vol. 80, no. 4, pp. 539–545, 1999
  30. Species and Strain Comparisons in the Macromolecular Binding of Extremely Low Doses of [14C]Benzene in Rodents, Using Accelerator Mass Spectrometry
    Toxicology and Applied Pharmacology, vol. 159, no. 2, pp. 83–90, 1999
  31. Dose-Dependent Binding of ortho-Phenylphenol to Protein but Not DNA in the Urinary Bladder of Male F344 Rats
    Toxicology and Applied Pharmacology, vol. 159, no. 1, pp. 18–24, 1999
  32. Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses
    Cancer Letters, vol. 143, no. 2, pp. 149–155, 1999
  33. Comparative biotransformation studies of MeIQx and PhIP in animal models and humans
    Cancer Letters, vol. 143, no. 2, pp. 161–165, 1999
  34. In vivo human metabolism of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
    Cancer Letters, vol. 143, no. 2, pp. 135–138, 1999
  35. Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification
    Toxicology Letters, vol. 102-103, no. 1-2, pp. 435–439, 1998
  36. Quantitative imaging microscopy for the sensitive detection of administered metal containing drugs in single cells and tissue slices—a demonstration using platinum based chemotherapeutic agents
    Journal of Pharmaceutical and Biomedical Analysis, vol. 17, no. 4-5, pp. 651–663, 1998
  37. Chemical Research in Toxicology, vol. 11, no. 3, pp. 217–225, 1998
  38. Chemical Research in Toxicology, vol. 11, no. 10, pp. 1217–1222, 1998
  39. Distribution and metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) in female rats and their pups at dietary doses
    Carcinogenesis, vol. 19, no. 5, pp. 919–924, 1998
  40. Investigation of the formation and accumulation of liver DNA adducts in mice chronically exposed to tamoxifen
    Carcinogenesis, vol. 18, no. 11, pp. 2209–2215, 1997
  41. Tissue distribution and macromolecular binding of extremely low doses of [14C]-benzene in B6C3F1 mice
    Carcinogenesis, vol. 18, no. 12, pp. 2421–2427, 1997
  42. A preliminary evaluation of accelerator mass spectrometry in the biomedical field
    Journal of Pharmaceutical and Biomedical Analysis, vol. 16, no. 3, pp. 541–543, 1997
  43. Dose-dependent binding of trichloroethylene to hepatic DNA and protein at low doses in mice
    Chemico-Biological Interactions, vol. 106, no. 2, pp. 109–121, 1997
  44. Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry
    Chemico-Biological Interactions, vol. 106, no. 2, pp. 149–160, 1997
  45. Metabolism of food-derived heterocyclic amines in nonhuman primates
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 376, no. 1-2, pp. 203–210, 1997
  46. MeIQx-DNA adduct formation in rodent and human tissues at low doses
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 376, no. 1-2, pp. 243–252, 1997
  47. Chemical Research in Toxicology, vol. 9, no. 3, pp. 574–579, 1996
  48. New Molecular Endpoints and Methods for Routine Toxicity Testing
    Fundamental and Applied Toxicology, vol. 26, no. 2, pp. 156–173, 1995
  49. Heterogeneous DNA Adduct Formation in Vitro by the Acetylated Food Mutagen 2-(Acetoxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine: A Fluorescence Spectroscopic Study
    Chemical Research in Toxicology, vol. 8, no. 5, pp. 659–670, 1995
  50. Chemical Research in Toxicology, vol. 7, no. 2, pp. 139–147, 1994
  51. DNA adducts in model systems and humans
    Journal of Cellular Biochemistry, vol. 53, no. S17F, pp. 138–148, 1993
  52. Biomolecular tracing through accelerator mass spectrometry
    TrAC Trends in Analytical Chemistry, vol. 11, no. 4, pp. 142–149, 1992
  53. Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA
    Mutation Research Letters, vol. 245, no. 3, pp. 185–190, 1990
  54. Accelerator Mass Spectrometry in Biomedical Dosimetry: Relationship Between Low-Level Exposure and Covalent Binding of Heterocyclic Amine Carcinogens to DNA
    Proceedings of the National Academy of Sciences, vol. 87, no. 14, pp. 5288–5292, 1990
  55. The metabolic disposition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the induced mouse
    Food and Chemical Toxicology, vol. 27, no. 10, pp. 667–673, 1989